Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: N1IOA09R6A

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-4 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Tuberculosis 2 D014376 ClinicalTrials
Asthma 2 D001249 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 331243-22-2
ChEMBL CHEMBL2108119
FDA SRS N1IOA09R6A
Guide to Pharmacology 7786